GLP-1 Receptor Agonist Effects on Lipid and Liver Profiles in Patients with Nonalcoholic Fatty Liver Disease: Systematic Review and Meta-Analysis

Aims. This meta-analysis of randomized placebo-controlled clinical trials assessed the effect of glucose-like peptide-1-receptor agonists (GLP-1RA) on the lipid profile and liver enzymes in patients with nonalcoholic fatty liver disease (NAFLD). Materials and Methods. Randomized placebo-controlled t...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Shahla Rezaei, Reza Tabrizi, Peyman Nowrouzi-Sohrabi, Mohammad Jalali, Stephen L. Atkin, Khalid Al-Rasadi, Tannaz Jamialahmadi, Amirhossein Sahebkar
Format: article
Langue:EN
Publié: Hindawi Limited 2021
Sujets:
Accès en ligne:https://doaj.org/article/575902276a12457aaf5580741dcd481a
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!